These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6661738)

  • 1. Mitoxantrone--a critique.
    Holland JF
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():77-9. PubMed ID: 6661738
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitoxantrone in acute lymphoblastic leukemia.
    Paciucci PA; Ohnuma T; Cuttner J; Silver RT; Holland JF
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():65-8. PubMed ID: 6581869
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial.
    Neidhart JA; Gochnour D; Roach RW; Steinberg JA; Young D
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():41-6. PubMed ID: 6362877
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():57-63. PubMed ID: 6362878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone as first line cytotoxic therapy in advanced breast cancer: preliminary results of a phase II study.
    Mouridsen HT; Rose C; Nooy MA; van Oosterom AT
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():47-52. PubMed ID: 6661734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone (novantrone): a review of experimental and early clinical studies.
    Smith IE
    Cancer Treat Rev; 1983 Jun; 10(2):103-15. PubMed ID: 6347376
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic activity of mitoxantrone and ametantrone against murine tumors.
    Schabel FM; Corbett TH; Griswold DP; Laster WR; Trader MW
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():13-21. PubMed ID: 6362874
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical safety and tolerance of mitoxantrone (Novantrone).
    Crossley RJ
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():29-36. PubMed ID: 6362875
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitoxantrone hydrochloride in lymphoma.
    Coltman CA; McDaniel TM; Balcerzak SP; Morrison FS; Von Hoff DD
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():73-6. PubMed ID: 6661737
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitoxantrone in malignant lymphomas.
    Gams RA; Keller JW; Golomb HM; Steinberg J; Dukart G
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():69-72. PubMed ID: 6661736
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitoxantrone.
    Nathanson L
    Cancer Treat Rev; 1984 Dec; 11(4):289-93. PubMed ID: 6534511
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitoxantrone in malignant melanoma.
    Presant CA; Gams R; Bartolucci A
    Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
    Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
    Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer.
    Smith IE; Stuart-Harris R; Pavlidis N; Bozek T
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():37-40. PubMed ID: 6661733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
    Williams SD; Birch R; Gams R; Irwin L
    Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593
    [No Abstract]   [Full Text] [Related]  

  • 16. Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial.
    DeSimone PA; Gams R; Bartolucci A
    Cancer Treat Rep; 1986 Jul; 70(7):929-30. PubMed ID: 3521850
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
    Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
    Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II studies of mitoxantrone (dihydroxyanthracenedione) in the treatment of advanced colorectal carcinoma.
    DeSimone PA; Gams R; Bartolucci A
    Am J Clin Oncol; 1984 Oct; 7(5):517-22. PubMed ID: 6507372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone for treatment of patients with refractory small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Von Hoff DD; Chen T; Clark GM; Callahan SK; Livingston R
    Cancer Treat Rep; 1983 Apr; 67(4):403-4. PubMed ID: 6303588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.